Background and objective: The uptake of new medicines is slower in the UK than in many
other countries. Previous research found that cost and price have little influence on general …

BACKGROUND: Ensuring appropriate prescribing is an important challenge for the health
service, and the need for research that takes account of the reasons behind individual …

Objective To analyse associations between indicators for adoption of new drugs and to test
the hypothesis that physicians' early adoption of new drugs is a personal trait independent of …

Background Medical specialists are often seen as the first prescribers of new drugs.
However, the extent to which specialists influence new drug prescribing in primary care is …

Objectives. The aim of this study was to understand the range of factors that influence GPs'
uptake of new drugs Methods. A total of 107 GPs selected purposively from high, medium …

Background: New drugs are cornerstones of clinical practice. However, when included in
practice in an erratic fashion, there is valid concern about uncertain risk–benefit for patients …

Background. Prescribing varies considerably between GPs, and a minority of GPs account
for a large proportion of new drug prescribing. Objective. Our aim was to explore the …

New drugs are frequently heavily prescribed early in their lifecycle, despite an absence of
adequate data documenting their effectiveness, safety and pharmacoeconomic value …

Aim To test the hypothesis that general practitioners (GPs) with high prescribing levels of
certain drugs will adopt new drugs belonging to the same therapeutic group faster than …

Focal points We describe results from a postal questionnaire sent to all GPs (general
practitioners) in two East London primary care trusts investigating perceived influences of …